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Abstract
Quantification of reactive oxygen species, is perplexing either in vivo or in vitro 
due to their short half-lives. Consequently, to define the magnitude of oxidative 
stress, the more stable oxidation products can be measured in biological samples. 
The oxidative stress leads to the lipid peroxidation that involves the initiation, 
termination and propagation of lipid radicals, wherein, the process involves the 
oxygen uptake, rearrangement of the double bonds in unsaturated lipids, that leads 
to polyunsaturated fatty acid deterioration. Subsequently, the toxic signaling end 
products are considered as biomarkers of free radicals that act both as signaling 
molecules and as cytotoxic products cause covalent alteration of lipid peroxidation 
products. The use of validated signaling mechanism (s) of Lipid peroxidation and 
products derived thereof exhibits its use clinical practice and basic clinical research 
as well as in clinical practice has become common place, and their presence as 
endpoints in clinical trials is now broadly accepted. This knowledge can be used to 
diagnose disease earlier, or to prevent it before it starts. The signaling markers can 
be used to excel the effectiveness of the prevailing medicines and to improve the 
new medicines.
Keywords: lipid peroxidation, isoprostanes, malondialdehyde, Alzheimer’s disease, 
oxidative stress
1. Introduction
Lipids are of two types: Polar and Non-polar. The polar lipids (Triglycerides), 
store in various cells but especially in adipose (fat) tissue, are usually the main 
source of energy for mammals. Polar lipids are underlying segments of cell layers, 
where in it contributesfor thedevelopment of permeability barrier of cells and sub-
cellular organelles in the form of a lipid bilayer [1]. The glycerol-based phospholipid 
is the significant type of membranous lipid bilayer and it is evidenced by the element 
that membrane lipids may regulates the biologicalfunctions of a membrane organelle 
by amending its biophysical characteristics, such as the divergence and absorptivity 
[2]. Lipids and its metabolite productsfacilitates a key ingredient in understand-
ing the biology and serve as a signaling biomolecules in the diagnosis of diseases 
[3]. However, theleading enzymes that generate as lipid-signaling biomarkers are 
lipoxygenase, that intervene hydroperoxyeicosatetraenoic acids (HPETEs), lipoxins, 
leukotrienes, or hepoxilins biosynthesis after oxidation of fatty acids/arachidonic 
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acid (AA), cyclooxygenase that yields prostaglandins, and cytochrome P-450 (CYP) 
that produces epoxyeicosatrienoic acids, leukotoxins, thromboxane, or prostacy-
clin respectively [4, 5]. The signaling lipid biomarkers recruitsvia stimulation of a 
variety of receptors, including nuclear and G protein-coupled receptors. Moreover, 
several othertypes of lipidmetabolites have been recognized as potent intracellular 
signal transduction molecules viz; i) diacylglycerol (DAG) and inositol phosphates 
(IPs) were derived from the phosphatidylinositol phosphates. DAG is a transcrip-
tion nuclear factor-kB (NF-kB) which promotes cell survival and proliferation and 
also a physiological activator of protein kinase C [6, 7] and a small G protein [8]. 
On the other hand, IPs (lipid derived metabolites) are anextremelystimulatingthat 
intricate in signal transduction, results in activation of mTORand Akt [9], and 
calcium homeostasis [10, 11]; ii) Sphingolipid derived from ceramide (sphingosine-
1-phosphate), is aeffective messenger molecule engaged in proliferation, adhesion, 
migration and alsoregulates calcium mobilization at molecular and cellular level of 
the organism [12–14]; iii) oxidative stress induced fatty acid derived eicosanoid and 
prostaglandins involved in inflammation [15, 16] and immunity [17]; iv) phosphoti-
dylserine, (a phospholipid) that plays crucial role in a number of signaling pathways, 
includes fusogenic proteins, kinases and small GTPases [18]; v) the sex and growth 
hormones such as testosterone, progesterone, estrogen and cortisol that monitored 
a host body activities such as reproduction, blood pressure metabolism, inflamma-
tion, oxidative stress response etc. [19].
Molecular mechanism of lipid damage: The process of lipid peroxidation (LPO), 
is the resultant of oxidative stress and free radical production. Specifically, reac-
tive oxygen species (ROS) attack polyunsaturated fatty acids (PUFAs) of cellular 
membranes and leads tothe insult of functional and/or structural integrity of cell 
membranes, subsequentlyproducing4-hydroxy-2-noneal (HNE), malondialdehyde 
(MDA) and acrolein (a group of α, β-unsaturated highly reactive aldehyde) [20, 21]. 
Therefore, these strong reactive aldehydes are significantlydiffusive, able to attack 
and form covalent linkages with auxiliary cellular constituents. Moreover, the lipid 
peroxidation process continues asself-propagation followed by initiation of chain 
reactions and termination either with complete substrate utilization or through 
interaction with antioxidants such as tocopherol (Vitamin E). Neuroprostanes 
(neuroPs), isoprostanes (IsoPs) are the additional LPO products of arachidonic 
acid and docosahexaenoic acid (DHA), that are quantified in the biological fluids to 
diagnose the severity of the disease. Furthermore, the cyclized fatty acids prolifer-
ate further and metabolize the cellular membrane components, mainly lipids and 
proteins, and propagates the other LPO products in the body fluids [22].
Quantification of reactive oxygen species, is perplexing either in vivo or in vitro 
due to their short half-lives. Consequently, to define the magnitude of oxidative 
stress, the more stable oxidation products can be measured in biological samples. 
The oxidative stress leads to the lipid peroxidation that involves the initiation, 
termination and propagation of lipid radicals, wherein, the process involves the 
oxygen uptake, rearrangement of the double bonds in unsaturated lipids, that leads 
to polyunsaturated fatty acid deterioration. Subsequently, the toxic signaling end 
products are considered as biomarkers of free radicals that act both as signaling 
molecules and as cytotoxic products cause covalent alteration of lipid peroxida-
tion products [23]. In respect of their oxidative-induced damage properties, these 
compounds are considered as disease mediators in the pathophysiology of many 
neurodegenerative diseases (NDs), including Alzheimer’s disease (AD), Parkinson’s 
disease (PD), and amyotrophic lateral sclerosis (ALS), Diabetes, Atherosclerosis, 
Chronic inflammation, Asthma and liver injury that serve as potential biomarkers 
in the signaling mechanism in diagnosis of diseases [24]. Thus, it is necessary to 
understand the oxidative deterioration of lipids in a sequential five-step procedure 
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in which oxidants, either radical or non-radical species, attack lipids containing 
C-C double bonds [25, 26]. On the contrary of enzyme-based lipid metabolism, 
lipid peroxidation does follow a non-enzymatic process that continues in ahysteri-
calmode: Initiation, propagation and termination (Figure 1) [27].
2. Mechanism of action of lipid peroxidation (LPO)
The process of LPO on membrane influences discrete functions from the 
increased rigidity of membrane, reduced action of membrane-confined enzymes, 
impairment of membrane receptors and modified permeability of the cell mem-
brane. Similar to phospholipid impairment, radicals can also directly attack lipid-
protein and membrane proteins mediate as well as protein–protein interconnection, 
subsequently affect the membrane integrity [28]. LPO products persuade such a loss 
of membrane integrity that ultimately leads to unadorned cytotoxicity, and could 
result in unrestrained cellular growth or even apoptosis. Rationally, the perturba-
tion of the above-mentioned functions ensued by polyunsaturated fatty acids, 
along with the resultant metabolites and protein insults modifies the neuronal 
homeostasis, and leads to the multi-organ organ dysfunction [29–31].
3.  Lipid peroxidation (LPO) products as biomarkers in 
neurodegenerative disorders
LPO products are significantly associated to the development of Alzheimer’s 
diseases (AD); and hence, they are studied as potential disease signaling biomark-
ers in neurodegenerative disorders. LPO products such as MDA, IsoPs, TBARS, 
and fluorescent lipofuscin-like pigments (LPF) extensively studied and found in 
different human samples (plasma, serum and urine) of the patients suffering from 
neurodegenerative disorders. (Summarized in Table 1).
Histopathological studies revealed a co-localization of lipid peroxidation 
products and β-amyloidplaques in the brain of the AD. Also, the studiy evident for 
the presence of fatty acids in AD brain lesions produced a neurotoxic effect in cell 
culture increasing oxidative stress [41]. Since the brain contains high lipid content 
and high oxygen consumption, lipid peroxidation seems to play fundamental 
role in AD early detection. Similarly, IsoPsand its isomers produced via diverse 
actions that, are encountered as marginal oxidation products of the arachidonic 
acid [42]. Whereas, neuroPsenriched in the neuronal tissue and vital component 
Figure 1. 
Oxidative deterioration of lipids.
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of the nervous tissues, awfully susceptible to oxidation [43]. Thus, the quantitative 
estimation of neuroPsaffords a significantsource of oxidative neuronal impairment-
corresponding to IsoPs [44].
Malondialdehyde (MDA) a signaling molecule of LPO has ability to interact 
with micro-macromolecules such as nucleic acid bases, developingdivergent 
adducts, and can also react with proteins in a synergistic and covalent manner, 
subsequently, leads to the stimulation of strong immune responses and exhibits 
pro-fibrogenic and pro-inflammatory properties/mediators such as interleukins, 
cytokines etc. Furthermore, accumulation of MDA modifies membrane integrity by 
inducing increased intra and extracellular permeability and damage the fluidity of 
membrane lipid bilayer. Being a most mutagenic, MDA is capable of reacting with 
deoxyadenosine in DNA and deoxyguanosine, thus generating mutagenic DNA 
adducts [21, 31].
As the consequence of peroxidation of PUFAs (linoleic and arachidonic acid), 
Hudroxy-2-nonrenal (HNE) are formed, since they are the most abundant in fatty 
acids. The HNE, specifically, bind to amino acids mainly: cysteine, histidine and 
lysine proteinaceous residue addition by either the amino and thiol groups. The 
conjugates of protein residue and HNE, leads to the impairment of the normal 
protein function as well as structure, and also HNE exhibits reactivity with vital 
nucleic acids, lipids, signaling biomolecules and vitamins. Documented reports, 
suggests that, the HNE accumulates in extremely low concentration (10 μM), in 
response to oxidative stress and induces cytotoxicity and selective suppression 
of inducible and basal NF-kB factors. Therefore, increased levels of HNE results 
in Ca2+ homeostasisimbalance, disruption of glutamate transport, membrane 
impairment, microtubule function, and cellular death via the activation of caspase 
pathways [28, 45].
Sr. no Biomarkers Biological 
sample
Analytical 
technique
Results Reference
01 8-Isoprostane Urine EIA AD <DrD*
AD+DM < DrD
[32]
02 Isoprostanes 
oxidized LDL
Urine ELISA Not differences between 
groups
[33]
03 8-Isoprotanes Serum ELISA Non-frail AD < Pre-frail 
AD*
[34]
04 Isoprostanes Urine EIA Non-frail AD < frail AD* [35]
05 Isoprostanes, 
Neuroprostanes, 
dihomo-isoprostanes
Urine RIA AD + placebo > AD 
treatment
[36]
06 MDA Urine GC–MS Not differences between 
groups after the 
treatment
[37]
07 MDA Urine UPLC-MS/MS Significant differences 
in groups
[38]
08 MDA Plasma HPLC-
fluoresce
aMCI converted >aMCI 
stable
[39]
09 MDA Blood HPLC-MS MDA blood levels do not 
correlated with different 
cognitive tests
[40]
Table 1. 
Signaling mechanism of lipid peroxidation in biological samples of patients.
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Threonine metabolite product, acrolein generated by the bio activation of 
phagocytes and cyclophosphamide. Wherein, acrolein targets histidyl, lysyl and 
cysteinyl residue of protein side chain as well as reactswith nucleophilic sites in 
DNA, that results in DNA and protein adducts and, thus, initiates cytotoxicity 
specifically related to its ability to reduce glutathione [46]. Docosahexaenoic acid 
(DHA) enriched in neurons, and is a vital compound of the nervous tissue. It is 
a vital compound of the nervous tissue and enriched in neurons and extremely-
susceptible to oxidation. DHA on oxidative stress, leads to the production of 
Neuroprostanes (F4-isoprostanes). In a biological aspect, neuroPsillustrates 
anti-inflammatory properties by inhibiting proteasome concentrated in the neurons 
membrane [45]. Nevertheless, the central nervous system (CNS) is one of the major 
targets of the LPO and proneto chain reactions induced by ROS, which eventually 
result in LPO products [47]. The role of LPO quantification in the pathogenesis of 
NDs is significant and extremely importance for the early detection of neurodegen-
erative disorders [45].
The most frequently exploited LPO products such as lysine residues and unsatu-
rated aldehydes, including HNE and aracolein [48]. Several research studies have 
been probing the LPO products and disease state interrelation, and its application 
as possible biomarkers in order to assess prognosis and establish early detection of 
the disease [49]. Among the above-mentioned potential biomarkers, IsoPssignifies 
the most reliable and robust outcomes. Moreover, the IsoPs accurately process and 
assessed the oxidant stress in vivovia quantification of plasma and urinary sample. 
Also, in situ phospholipids composed of IsoPs that locates the free radical produc-
tion and release from the cellular membrane via phospholipases in the plasma. 
IsoPs detected and quantified in a plethora of biological fluids including plasma 
cerebrospinal fluid, exhaled breath condensate, urine and bile [50]. On the other 
hand, neuroPs are a fundamental component of the nervous tissue, enriched in 
the neuronal tissue and extremely susceptible to oxidation [51]. Thus, the quanti-
fication of neuroPs provides a signaling biomarker of oxidative neuronal damage 
compare to IsoPs quantification. In addition, the quantity of neuroPs produced 
Figure 2. 
Lipid peroxidation (LPO) products as biomarkers in neurodegenerative disorders.
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from DHA surpass that of IsoPs from arachidonic acid by 3.4 folds. NeuroPsare 
elevated in the cerebrospinal fluid and brain tissue in ND, such as Parkinson and 
Alzheimer’s disease. Hence, quantification of neuroPs levels isa vital tool in evaluat-
ing brain oxidative impairment [52]. Whereas, crosslinking is a major factor in the 
development of pathology due to the promotion of intramolecular or intermolecu-
lar DNA and protein cross-linking, which results in intense change in the bio-
chemical properties of various biomolecules (Figure 1). This articulated process is 
assumed to be a channel of interrelation chain reactions with covalent nucleophilic 
compounds. Also, the translated and interconnected experimental indicators with 
precise altered proteins in the CNS exhibited those definite cellular amendments 
are in concomitant with pathophysiology of Neurodegenerative diseases. Thus, the 
revival of scientific data affords a comprehensive knowledge in the advancement 
and employment of LPO products as potential biomarkers in the early diagnosis 
of the disease, alteredbiological processes, revealing potential active sites to target 
disease progression (Figure 2).
4.  Lipid peroxidation metabolites as influential signaling biomarkers in 
asthma and airway inflammation
Oxidative stress at molecular and cellular level can have many detrimental effects 
on airway function, including airway smooth muscle contraction, induction of air-
way hyper responsiveness, mucus hypersecretion, vascular exudation and shedding 
of epithelial cells. Furthermore, ROS can induce cytokine and chemokine production 
through induction of the oxidative stress-sensitive transcription of nuclear factor–kB 
in bronchial epithelial cells [53]. Recently discovered series of bioactive prostaglan-
din (PF)F2-like compoundswere produced independently of the cyclooxygenase 
enzymes via the peroxidation of arachidonic acid, catalyzed by free radicals. The 
pathway leads to formation of 64 isomeric structures, of which 8-iso-PGF2α is most 
well characterized. Evidence suggests that 8-iso-PGF 2α may act in part through 
the vascular thromboxane A2/PGH2 (TP) receptor [54]. 8-iso-PGF2α has been 
found to elicit airway hyper-responsiveness in isolated perfused mouse lungs, and 
cause airway obstruction and air plasma exudation in guinea pigs in vivo [55]. These 
experimental findings offerassumption about the contribution of Isoprostanes to the 
airway narrowing that is characteristic of asthma and in addition to being reliable 
signaling marker of lipid peroxidation, Isoprostane may prove to have an important 
biological role in the pathological of asthma. A significant elevation of reactive 
oxygen species, MDA formation (A product of Lipid peroxidation) and Isoprotane 
was estimated in the broncho-alveolar lavage (BAL) fluidwithin 24 hrs of allergen-
induced asthma. This clearly indicates, Isoprotane is produce as a biomarker in 
respiratory tract tissues that leads to the late observed physical symptoms in allergen-
induced asthma [56].
A recent study demonstrated that concentrations of exhaled ethane were 
increased in patients with more severe bronchoconstriction (forced expiratory 
volume in one second (FEV1) <60%), compared with less-constricted patients 
(FEV1 > 60%) and provides evidence that lipid peroxidation is related to asthma 
severity. These relationships between markers of oxidative stress and disease severity 
suggest that such tests may indicate the clinical status of asthma patients [57]. The 
increased level of 8-sio-PGF2α concentrations has been observed in chronic obstruc-
tive pulmonary diseases and asthma [58]. The discovery of Isoprostane has generated 
attention, as they provide a reliable index of oxidative stress in vivo. Isoprostane are 
structurally stable, are produced in vivo and are present in relatively high concentra-
tions [59]. Traceable levels of F2-isoprostanes can be found in all normal animal and 
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human biological fluids (including plasma, urine, bile, gastric juice, synovial fluid 
and cerebrospinal fluid)), and esterified in normal animal tissues. Thus, they over-
come many of the methodological problems associated with other signaling markers. 
Determination of 8-iso-PGF2αas a marker of oxidative stress, of carbon tetrachloride 
(CCl4)-induced lipid peroxidation has been shown to be 20 times more sensitive than 
measurement of Thiobarbituric acid reactive substances (TBARS). Thus, the reliabil-
ity of isoprostanes as in vivo markers of lipid peroxidation makes them an extremely 
valuable signaling biomarker for defining the potential of antioxidant agents 
(Vitamin C, E and β-carotene) in humans [60]. A significant amount of elevated 
ethane produced following lipid peroxidation has been observed in plasma and breath 
condensate of asthmatics as a biomarker indicator of acute airway inflammatory 
diseases. Moreover, measurement of auto-antibodies directed against oxidative modi-
fications of low density lipids (LDL) is a recently developed technique that provides 
an in vivo marker of lipid peroxidation. Enzymes-linked immunosorbent assays are 
available in kit form, providing a quick and simple methodology. Thus measurement 
of isoprostanes in breath condensate should provide useful information concerning 
the degree of oxidant stress and success of antioxidant therapy in asthma (Figure 3).
5. Lipid peroxidation: a signaling mechanism in diagnosis of liver injury
Oxidative stress is one of the mechanisms involved in the pathogenesis of 
drug-induced reactive oxygen species which lead to the depletion of intracel-
lular antioxidants, causing an imbalance in the redox status of the hepatic cells 
[61]. Rapid, extensive lipid peroxidation of the membrane structural lipids due 
to oxidative stress mechanism involved in the pathogenesis of drug-induced had 
seen proposed as the basis of drug-induced hepatocellular toxicity. The most of the 
xenobiotics such as Acetaminophen, Isoniazid and Rifampicin are well-known to 
Figure 3. 
Lipid peroxidation metabolites as influential signaling biomarkers in lung diseases.
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induced hepatic damage directly or indirectly via lipid peroxidation [62]. However, 
peroxy radical attribute to lipid peroxidation, thus known for the destabilization 
and disintegration of the cell membrane, that further causes arteriosclerosis, 
hepatic and kidney damage. The increased serum markers such as MDA formation 
are of diagnostic importance of hepatic injury because they are released due to the 
damage of hepatocytes and consequently participate in endogenous enzymatic 
antioxidant system imbalance [63]. CCl4-ehanced lipid peroxidation has been 
observed in liver tissue homogenates, isolated hepatocytes and in vivo, and this 
has been associated with changes in endoplasmic reticular enzyme activity, in vivo 
fatty acid export and protein synthesis [64]. CCL4 metabolism enhances produc-
tion of malondialdehyde in vitro and increase ethane production and lethality in 
vivo (Figure 4). Consequently, lipid peroxidation initiated by free radical reactions 
and unchecked by compromised cellular defenses, provides a possible link between 
Figure 4. 
Lipid peroxidation: a signaling mechanism in diagnosis of liver injury.
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ethanol metabolism and associated liver disease [65]. The lipid peroxide content 
of liver is elevated by both short and long-term ethanol exposure and an enhanced 
rate of lipid peroxide formation following ingestion has been ascertained by MDA 
production, diene conjugate formation and in vivo ethane and pentane exhalation. 
Lipid peroxidation might merely be a sign of oxidative processes which occur after 
reduced glutathione is depleted concomitant with free radical attack on cellular 
protein and nucleic acid. The elevated MDA formation as a product of lipid per-
oxidation in drug-induced liver damage provide a significant biological signaling 
marker for the early detection or diagnosis of liver injury.
6. Conclusion
The oxidative stress inducing compounds mediates metabolic process of lipids 
mainly via peroxidation that leads to the production of macromolecules such as 
Isoprostane, MDA, 4-HNE in the biological fluids. Moreover, the aldehyde like 
molecules produced via lipid peroxidation targets and modifies proteins and DNA 
substantially at macromolecule level. Furthermore, MDA and 4-HNE known to 
promote cross linking of protein/DNA reactions that significantly alleviates and 
alters the biomarkers biochemical property, thereby develops a clinical symptom-
atic states. The use of validated signaling mechanism (s) of Lipid peroxidation and 
products derived thereof in basic and clinical research as well as in clinical practice 
has become common place, and their presence as endpoints in clinical trials is now 
broadly accepted. This knowledge can be used to diagnose disease earlier, or to 
prevent it before it starts. The signaling markers can be used to improve the efficacy 
and safety of existing medicines and to develop new medicines.
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